Mohamed Issa

Heading the operations in Africa, Turkey, Iraq and India

Ophthalmology Unit :
• Responsible for driving growth of Ophthalmology business Unit in 30 Countries (international markets CIS, Asia & Africa) via marketing, registration & in-licensing of new compounds.
• Directing partnership activities with key internal functions including commercial regions, supply chain, regulatory, legal, QA, and finance.
• Setting up contracts and negotiating all financial principles.
• Further the company’s global-scale efficiency and competitiveness.
Effective management to cope with the pressures and uncertainties of the dynamic business environment in different international markets.
• Recognize opportunities and risks across international and functional boundaries.
Coordinate activities and link capabilities across international barriers.

Country Responsibility :
• Market manager responsible for accessing Nigeria, Ghana & Tunisia pharmaceutical markets.

• June 2010 till now responsible for both product planning and product marketing.
• This includes managing the product throughout the product lifecycle, gathering and prioritizing product and customer requirements, defining the product vision, and working closely with Sales managers, to deliver winning products. Support to ensure revenue and customer satisfaction goals are met.
• Ensuring that the product and marketing efforts support the company's overall strategy and goals.
• Responsible for Derma line (Systemic Antiviral - Topical Antiviral - Antifungul - Wound Healing Agents) - Bone Line (Osteoporosis) - CVS line (Angina Nitrates - Hypertension) - Chest line (Common Cold - Anti-tussive - Antibiotic).

Responsible for Bone, Anti-rheumatic, franchise in Gharbia, (3 Lines/ 10 Reps.).
Ranked on Top 5 District managers for Sales Achievement 110% Vs Target 2009 for Bone Line Sales.
Certified as Best Captainship Award as team leader (Deliver Highest team productivity with all team Ranked as A representatives in 2008)
Certified as Global BEST practice award from Novartis - Switzerland 2009 For Managing Project Nucleus

Certified as No. 1 Best Achiever Novartis Pharmaceutical Egypt Sales Representative 2004 for Bone Line Sales and MS Vs. Target.
Successfully launch Catafast with 140% Vs. target for 2 successive years.
Successfully launch Flotac with 260% Vs. target and highest MS 5% on National Level.
A1A1 in ABCD Matrix for 2005 and 2006 and Ranked from Top 3 on National Level.
Selected for piloting Siebel Focus Egypt as new reporting system 2006.